Major pharmaceutical companies continually research and develop new medications and treatments, which must be shown to be safe and effective before the FDA ( Food and Drug Administration) approves them and doctors can prescribe them to patients. Through prostate cancerclinical trials, researchers test the effects of new medications on a group of volunteers with prostate cancer. Following a strict protocol and using carefully controlled conditions, researchers evaluate the investigational drugs under development and measure the ability of the new drug to treat prostate cancer, its safety, and any possible side effects.
Some patients with prostate cancer are reluctant to take part in clinical trials for fear of getting no treatment at all for their prostatecancer. This is simply not true. Patients with prostate cancer who participate in prostate cancer clinical trials receive the most effective therapy available for their condition -- or they may receive prostate cancer treatments that are being evaluated for future use. These prostate cancer drugs may be even more effective than the current prostate cancer treatment.
As cancer diagnoses go, prostate cancer is often a less serious one. Prostate cancer is frequently slow-growing and slow to spread. For many men, prostate cancer is less serious than their other medical conditions.
For these reasons, and possibly because of earlier detection of low-grade prostate cancers, prostate cancer has one of the highest survival rates of any type of cancer. WebMD takes a look at prostate cancer survival rates and what they mean to you.
This web site, developed by the nonprofit Coalition of Cancer Cooperative Groups, is an unbiased cancer clinical trial matching and navigation service that enables patients to search for cancer trials based on disease and location.